Skip to content

Integra LifeSciences IART Net Investment in Lease

Net Investment in Lease at other companies

Axogen logo
AxogenAXGN
Globus Medical logo
Globus MedicalGMED
STERIS logo
STERISSTE
ITG
Integer HoldingsITGR
Merit Medical Systems logo
Merit Medical SystemsMMSI
Boston Scientific logo
Boston ScientificBSX

Other financials

Income statement

See full
Revenue$391.9M+2.4%
Gross profit$217.0M+11.6%
Operating income$11.5M+174%
Net income-$4.6M+81.7%
EPS (diluted)-$0.06+81.8%

Balance sheet

See full
Cash & equivalents$236.8M-1.0%
Total debt$2.0B+3.2%
Total equity$1.0B-31.6%
Total assets$3.6B-11.7%

Cash flow

See full
Operating cash flow$9.8M+187%
CapEx$14.8M-48.7%
Free cash flow-$5.0M+87.4%

Valuation

See full
Market cap$1.38B-56.8%
Enterprise value$3.12B-26.7%
P/S0.8×-1.1×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin-29.8%-30.3pp
Net margin-30.1%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-38.6%
Debt / equity1.9×+0.6×
Current ratio3.4×+2.2×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integra LifeSciences's net investment in lease?
Integra LifeSciences (IART) reported net investment in lease of $137.2M in Q1 2026.
How has Integra LifeSciences's net investment in lease changed year-over-year?
Integra LifeSciences's net investment in lease decreased by 0.9% year-over-year, from $138.46M to $137.2M.
What is the long-term trend for Integra LifeSciences's net investment in lease?
Over 5 years (2020 to 2025), Integra LifeSciences's net investment in lease has grown at a 10.9% compound annual growth rate (CAGR), from $83.64M to $140.57M.